3 competitors Fool believe will outperform Tesla stock over the next 5 years

Tesla is probably the most volatile stock in the Magnificent Seven stock: just take a look at its share-price chart over the last year.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

EV electric vehicle charging station

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Tesla (NASDAQ:TSLA) has been one of the world’s most traded stocks for some time now. But today, we’re here to allow our contract writers to put forward a few other companies for investors to consider buying instead…

Li Auto

What it does: Li Auto is a Beijing-based carmaker specializing in extended-range electric vehicles (EREVs).

By James Fox. Li Auto (NASDAQ:LI) surged in the early months of 2024 but has since plummeted. The selloff can be traced to the unsuccessful launch of its first full-battery electric vehicle (EV) and poor Q1 deliveries. 

The failure of the Li Mega (the first full-battery EV) is a cause for concern, and the company has seemingly shelved some of its EV plans.

However, with its focus on EREVs – essentially hybrids with very long range – the company continues to deliver impressive volume growth, up 38.4% year to date. 

It also boasts the strongest margins in China’s new energy vehicle (NEV) market, trumping much larger peers like Tesla and BYD

Interestingly for investors, its stock is much cheaper than Tesla and modestly cheaper than BYD. The company trades at 16.8 times forward earnings, but forecasts suggest earnings will double over the next two years.

Li is also less likely to be impacted by tariffs and trade wars. The Beijing firm appears to be set on entering the MENA market as it starts to export. 

James Fox owns shares in Li Auto.

Nvidia

What it does: Develops and manufactures GPUs and chip systems for use in data centres, gaming, AI, and robotics.

By Mark David Hartley. The recent move into building its own AI computer chips means Tesla could soon be competing with Nvidia (NASDAQ: NVDA). While both companies have enjoyed impressive growth in the past five years, I think Nvidia will outpace Tesla in the next five. As Tesla’s car business faces competition, it appears to be branching into other sectors. The lack of focus on a single sector could cost its bottom line. 

Nvidia remains a market leader in its niche and its closest competitors, Broadcom and AMD, lag behind the company growth-wise. Moreover, Nvidia is the supplier of choice for tech giants like Meta and Microsoft. Tesla may find a limited market for its AI chips beyond its own automated products.

Both are overvalued but Nvidia’s price-to-earnings growth (PEG) ratio of 2.5 is lower than Tesla’s 3.6. It’s also forecast to grow at a rate of 22% per year, compared to Tesla’s 16%.

Mark David Hartley owns shares in AMD.

Smith & Nephew

What it does: Smith & Nephewis listed on the FTSE 100 and is a provider of medical technologies and treatments.

By Royston Wild. As sales of his Tesla electric vehicles stall, chief executive Elon Musk is doubling down on robotics to get the top line moving again. He hopes his Optimus humanoid robots will begin rolling off the production lines next year.

This isn’t tempting me to buy Tesla shares, though. Not only do troubles at its core carmaking division seem to be intensifying. Musk’s robot dreams have already suffered some setbacks (they were originally scheduled to be in Tesla’s factories by the end of 2024).

I think Smith & Nephew (LSE:SN.) could be a better stock to buy today. It’s primarily known for its joint replacement systems and work in wound care and sports medicine. However, it’s also investing heavily in robotics, and its CORI surgical system (used for knee operations) is a market leader.

CORI sales hit record highs in the second quarter as new product lines and capabilities were added to the platform. This could be a significant source of earnings growth as demand for medical robotics systems takes off.

Analysts at Grand View Research think this tech segment will rise at a compound annual growth rate of 16.6% between now and 2030. Smith & Nephew could be a top stock to capitalise on this.

Royston Wild does not own shares in Smith & Nephew or Tesla.

The Motley Fool UK has recommended Advanced Micro Devices, Microsoft, Nvidia, Smith & Nephew Plc, and Tesla. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Young Caucasian woman with pink her studying from her laptop screen
Investing Articles

New to investing? Here’s Warren Buffett’s strategy for starting from scratch

Warren Buffett says he could find opportunities to earn a 50% annual return in the stock market if he was…

Read more »

Investing Articles

Can the sensational Barclays share price do it all over again in 2026?

Harvey Jones is blown away by what the Barclays share price has been doing lately. Now he looks at whether…

Read more »

Investing Articles

Prediction: in 2026 mega-cheap Diageo shares could turn £10,000 into…

Diageo shares have been burning wealth lately but Harvey Jones says long-suffering investors in the FTSE 100 stock may get…

Read more »

Investing Articles

This overlooked FTSE 100 share massively outperformed Tesla over 5 years!

Tesla has been a great long-term investment, but this lesser-known FTSE 100 company would have been an even better one.

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

I’m backing these 3 value stocks to the hilt – will they rocket in 2026?

Harvey Jones has bought these three FTSE 100 value stocks on three occasions lately, averaging down every time they fall.…

Read more »

Investing Articles

Can the barnstorming Tesco share price do it all over again in 2026?

Harvey Jones is blown away by just how well the Tesco share price has done lately, and asks whether the…

Read more »

Investing Articles

Up 45% in a year with a 7.2% yield and a P/E of 13! Is it too late to buy this fabulous FTSE 250 stock?

Harvey Jones spotted the potential in this ultra-high-yielding FTSE 250 recovery stock, and is thrilled to see it starting to…

Read more »

Investing Articles

What on earth’s going to happen to the BP share price in 2026?

Harvey Jones looks at how the BP share price is shaping up for the year ahead, and finds investors have…

Read more »